Minerva Imaging is a scientifically driven contract research organization (CRO) that specializes in molecular imaging services for accelerated and efficient drug development. With a focus on translational cancer research and drug development, Minerva Imaging utilizes advanced oncology models and molecular imaging techniques to provide answers to scientific questions. Their comprehensive range of services includes in vitro and ex vivo capabilities, flow cytometry, histology, in vivo pharmacology, radionuclide therapy, molecular imaging, and more.

Founded in 2011, Minerva Imaging has built its expertise on over two decades of research conducted at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark. They work closely with clients to understand their specific scientific needs and perspectives, offering tailored solutions that meet their requirements. With a dedicated team of experienced professionals, including senior management, department managers, and a Board of Directors, Minerva Imaging brings extensive knowledge and industry-leading capabilities to the field of molecular imaging.

To join their team or learn more about their services, visit their website or contact them directly